Finding the Emperor Some Clothes
Executive Summary
Patent expiration is a fact of life for big pharma companies. But several leading firms, including Merck, Lilly, Warner-Lambert and Schering-Plough face significant threat at the turn of the century, with products generating anywhere from 20-45% of 1996 sales going off patent.